Pörssitiedote8.8.2025 klo 13.30The Swedish Companies Registration Office has granted permission to implement the merger plan between Flerie and Toleranzia
Pörssitiedote25.6.2025 klo 16.10Toleranzia applies for delisting of the Company’s shares from Nasdaq First North Growth Market, conditional upon completion of the merger with Flerie
Pörssitiedote5.6.2025 klo 10.20Announcement from the 2025 Annual General Meeting of Toleranzia AB (publ)
Pörssitiedote25.3.2025 klo 9.32Statement by the Board of Directors of Toleranzia in view of the merger offer by Flerie
Pörssitiedote25.3.2025 klo 9.30Flerie and Toleranzia have agreed on a merger plan to take Toleranzia private
Lehdistötiedote11.3.2025 klo 8.55Toleranzia seeks a scientific advice meeting with the Danish Medicines Agency
Pörssitiedote20.2.2025 klo 14.57Toleranzia’s clinical trial application (CTA) for TOL2 approved in Germany while declined in Denmark